SR
Srinivasa Rao Vankayalapati
About Srinivasa Rao Vankayalapati
Data last updated:
Srinivasa Rao Vankayalapati is a Director at Unitygrowth Investments Private Limited (since 2021), Director at New Line Medicines Private Limited (since 2016) and Director at Arrien-Rajendra Spinning Mills Private Limited (since 2011), and holds 1 more current directorship. The companies operate in Financial Services, Chemicals and Manufacturing. The 3 current companies with reported revenue have a combined latest revenue of ₹64.7 Lakh; the largest is Unitygrowth Investments Private Limited at ₹64.4 Lakh (FY 2025). Earlier, Srinivasa Rao Vankayalapati was a Whole-Time Director at Appcure Labs Private Limited (2012–2021) and Whole-Time Director at Alveus Pharmaceuticals Private Limited (from 2010) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unitygrowth Investments Private Limited U65993TG2021PTC157318 | Director | 25 Nov 2021 | 2021 | ₹64.4 Lakh (FY 2025) | Active |
| New Line Medicines Private Limited U24100AP2016PTC098568 | Director | 19 Mar 2016 | 2016 | ₹13,700 (FY 2025) | Active |
| Arrien-Rajendra Spinning Mills Private Limited U17200TG2011PTC074738 | Director | 30 May 2011 | 2011 | ₹12,500 (FY 2025) | Active |
| Rxbridge Pharma Private Limited U46497TS2026PTC210111 | Director | 23 Jan 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Appcure Labs Private Limited U24232TG2012PTC084625 | Whole-Time Director | 05 Dec 2012 | 2012 | ₹23.08 Cr (FY 2025) | Amalgamated |
| Alveus Pharmaceuticals Private Limited U24232TG2009PTC065531 | Whole-Time Director | 20 Dec 2010 | 2009 | ₹1.03 Cr (FY 2016) | Strike Off |
| Arrien Infrastructure India Private Limited U45200AP2010PTC071851 | Whole-Time Director | 23 Dec 2010 | 2010 | ₹37,000 (FY 2017) | Strike Off |
| Arrien Homes Private Limited U45209TG2013PTC086726 | Director | 01 Apr 2013 | 2013 | ₹21,100 (FY 2017) | Strike Off |
| Oros Pharmaceuticals Private Limited U73100TG2009PTC065273 | Whole-Time Director | 20 Dec 2010 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Srinivasa Rao Vankayalapati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Komala Devi Vankayalapati | 03429773 | Unitygrowth Investments Private Limited , New Line Medicines Private Limited and 2 more | Director |
| Appalaneni Anitha Pothula | 03369698 | Arrien-Rajendra Spinning Mills Private Limited | Director |
| Appalaneni Rajendra Prasad | 03315589 | Arrien-Rajendra Spinning Mills Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivasa Rao Vankayalapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivasa Rao Vankayalapati
Srinivasa Rao Vankayalapati currently holds 4 directorships: Unitygrowth Investments Private Limited (Director, since 25 Nov 2021, revenue ₹64.4 Lakh (FY 2025)); New Line Medicines Private Limited (Director, since 19 Mar 2016, revenue ₹13,700 (FY 2025)); Arrien-Rajendra Spinning Mills Private Limited (Director, since 30 May 2011, revenue ₹12,500 (FY 2025)); Rxbridge Pharma Private Limited (Director, since 23 Jan 2026).
Srinivasa Rao Vankayalapati was first appointed on 20 Dec 2010 as Whole-Time Director at Alveus Pharmaceuticals Private Limited. The most recent appointment on record is 23 Jan 2026 at Rxbridge Pharma Private Limited.
The 3 current companies of Srinivasa Rao Vankayalapati that report revenue have a combined latest revenue of ₹64.7 Lakh: Unitygrowth Investments Private Limited ₹64.4 Lakh (FY 2025); New Line Medicines Private Limited ₹13,700 (FY 2025); Arrien-Rajendra Spinning Mills Private Limited ₹12,500 (FY 2025).
Srinivasa Rao Vankayalapati held 5 earlier board appointments: Appcure Labs Private Limited (Whole-Time Director, 05 Dec 2012 to 10 Nov 2021); Alveus Pharmaceuticals Private Limited (Whole-Time Director, from 20 Dec 2010); Arrien Infrastructure India Private Limited (Whole-Time Director, from 23 Dec 2010); Arrien Homes Private Limited (Director, from 01 Apr 2013); Oros Pharmaceuticals Private Limited (Whole-Time Director, from 20 Dec 2010).
The current boards of Srinivasa Rao Vankayalapati's companies include Komala Devi Vankayalapati (Unitygrowth Investments Private Limited), Appalaneni Anitha Pothula (Arrien-Rajendra Spinning Mills Private Limited), Appalaneni Rajendra Prasad (Arrien-Rajendra Spinning Mills Private Limited).